This inventor holds 6 USPTO granted patents. Top assignees: Aventis Pasteur Limited, Connaught Laboratories Limited, Aventis Pasteur Limited/aventus Pasteur Limitee. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 75 
2 out of 145 
1 out of 1 Years Active: 2000-2003
Title: Innovations of Kenneth K Sokoll
Introduction
Kenneth K Sokoll is a notable inventor based in Alton, California. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative delivery systems for vaccines and therapeutic agents. With a total of 6 patents, his work has the potential to impact the way vaccines are administered and how immune responses are generated.
Latest Patents
One of Kenneth K Sokoll's latest patents is a biodegradable targetable microparticle delivery system. This invention involves copolymers designed for use as particulate carriers that contain functionalizable amino acid subunits for coupling with targeting ligands. The copolymers are polyesters composed of α-hydroxy acid subunits such as D,L-lactide and pseudo-α-amino acid subunits derived from serine. The stable vaccine preparations described in this patent are useful as delayed release formulations containing antigens and adjuvants encapsulated within or physically mixed with polymeric microparticles. These particulate carriers are designed to deliver agents to the immune system of a subject through mucosal or parenteral routes, thereby producing immune responses, including antibody and protective responses.
Career Highlights
Throughout his career, Kenneth K Sokoll has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Aventis Pasteur Limited and Connaught Laboratories Limited. His experience in these organizations has contributed to his expertise in vaccine development and delivery systems.
Collaborations
Kenneth has collaborated with several professionals in his field, including Pele Chong and Michel Henri Klein. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in vaccine delivery.
Conclusion
Kenneth K Sokoll's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as a significant inventor. His work in developing biodegradable microparticle delivery systems is poised to enhance vaccine efficacy and improve public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile